Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Serum Albumin in Cirrhotic Ascites
NCT06553456Phase 3Completed
- Sponsor
- Protogen
- Start
- Aug 2024
- Primary completion
- May 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human serum albumin in ascites, sponsored by Protogen. Started Aug 2024; status: completed.
02
Drugs
recombinant human serum albumin
03
Conditions
ascites
Beyond the preview
Go deeper on NCT06553456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06553456.